New quest diagnostics health trends® study, in collaboration with cdc, shows less than half of pregnant people screened for hepatitis c

Nationally representative study of more than 5 million pregnant people finds those with medicaid less likely to be screened than those with commercial insurance, demonstrating disparities in prenatal care secaucus, n.j. , june 13, 2022 /prnewswire/ -- a new health trends® study from quest diagnostics (nyse: dgx) developed in collaboration with the centers for disease control and prevention (cdc) found that the rate of hepatitis c (hcv) antibody screening increased 145% in pregnant people during the decade-long study period ending june 2021, but is still low, with nearly 41% of pregnant people receiving screening in early 2021.the study, which was published in obstetrics & gynecology, is believed to be the first large scale, nationally representative analysis of the impact of medical guidelines on screening for hcv in pregnancy, based on deidentified test results of more than five million pregnant people across the united states.
DGX Ratings Summary
Quant
DGX Quant Ranking
Sector
Industry
Quant Rating
Quant Score